10:41 AM EDT, 05/14/2024 (MT Newswires) -- Viracta Therapeutics ( VIRX ) said Tuesday it has appointed Michael Faerm as chief financial officer, effective immediately.
Faerm most recently served as interim finance chief at Harpoon Therapeutics, Viracta said.
Shares of the company were up 8.3% in Tuesday trading.
Price: 0.84, Change: +0.07, Percent Change: +8.33